Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Coronavirus disease - COVID-19 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
2 Coronavirus disease - COVID-19 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
3 Coronavirus disease - COVID-19 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
4 Coronavirus disease - COVID-19 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
5 Coronavirus disease - COVID-19 💬
1件: JAK1 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
6 Coronavirus disease - COVID-19 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
7 Coronavirus disease - COVID-19 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
8 Coronavirus disease - COVID-19 💬
2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
9 EGFR tyrosine kinase inhibitor resistance 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
10 EGFR tyrosine kinase inhibitor resistance 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
11 EGFR tyrosine kinase inhibitor resistance 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
12 EGFR tyrosine kinase inhibitor resistance 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
13 EGFR tyrosine kinase inhibitor resistance 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
14 EGFR tyrosine kinase inhibitor resistance 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
15 EGFR tyrosine kinase inhibitor resistance 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
16 EGFR tyrosine kinase inhibitor resistance 💬
2件: JAK1, JAK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
17 Epstein-Barr virus infection 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
18 Epstein-Barr virus infection 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
19 Epstein-Barr virus infection 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
20 Epstein-Barr virus infection 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
21 Epstein-Barr virus infection 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
22 Epstein-Barr virus infection 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
23 Epstein-Barr virus infection 💬
2件: JAK1, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
24 Epstein-Barr virus infection 💬
3件: JAK1, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
25 Hepatitis B 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
26 Hepatitis B 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
27 Hepatitis B 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
28 Hepatitis B 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
29 Hepatitis B 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
30 Hepatitis B 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
31 Hepatitis B 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
32 Hepatitis B 💬
4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
33 Hepatitis C 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
34 Hepatitis C 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
35 Hepatitis C 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
36 Hepatitis C 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
37 Hepatitis C 💬
1件: JAK1 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
38 Hepatitis C 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
39 Hepatitis C 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
40 Hepatitis C 💬
2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
41 Herpes simplex virus 1 infection 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
42 Herpes simplex virus 1 infection 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
43 Herpes simplex virus 1 infection 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
44 Herpes simplex virus 1 infection 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
45 Herpes simplex virus 1 infection 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
46 Herpes simplex virus 1 infection 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
47 Herpes simplex virus 1 infection 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
48 Herpes simplex virus 1 infection 💬
3件: JAK1, JAK2, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
49 Human cytomegalovirus infection 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
50 Human cytomegalovirus infection 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
51 Human cytomegalovirus infection 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
52 Human cytomegalovirus infection 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
53 Human cytomegalovirus infection 💬
1件: JAK1 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
54 Human cytomegalovirus infection 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
55 Human cytomegalovirus infection 💬
1件: JAK1 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
56 Human cytomegalovirus infection 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
57 Human papillomavirus infection 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
58 Human papillomavirus infection 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
59 Human papillomavirus infection 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
60 Human papillomavirus infection 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
61 Human papillomavirus infection 💬
1件: JAK1 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
62 Human papillomavirus infection 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
63 Human papillomavirus infection 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
64 Human papillomavirus infection 💬
2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
65 Human T-cell leukemia virus 1 infection 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
66 Human T-cell leukemia virus 1 infection 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
67 Human T-cell leukemia virus 1 infection 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
68 Human T-cell leukemia virus 1 infection 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
69 Human T-cell leukemia virus 1 infection 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
70 Human T-cell leukemia virus 1 infection 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
71 Human T-cell leukemia virus 1 infection 💬
2件: JAK1, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
72 Human T-cell leukemia virus 1 infection 💬
2件: JAK1, JAK3 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
73 Influenza A 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
74 Influenza A 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
75 Influenza A 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
76 Influenza A 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
77 Influenza A 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
78 Influenza A 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
79 Influenza A 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
80 Influenza A 💬
3件: JAK1, JAK2, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
81 JAK-STAT signaling pathway 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
82 JAK-STAT signaling pathway 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
83 JAK-STAT signaling pathway 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
84 JAK-STAT signaling pathway 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
85 JAK-STAT signaling pathway 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
86 JAK-STAT signaling pathway 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
87 JAK-STAT signaling pathway 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
88 JAK-STAT signaling pathway 💬
4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
89 Kaposi sarcoma-associated herpesvirus infection 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
90 Kaposi sarcoma-associated herpesvirus infection 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
91 Kaposi sarcoma-associated herpesvirus infection 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
92 Kaposi sarcoma-associated herpesvirus infection 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
93 Kaposi sarcoma-associated herpesvirus infection 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
94 Kaposi sarcoma-associated herpesvirus infection 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
95 Kaposi sarcoma-associated herpesvirus infection 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
96 Kaposi sarcoma-associated herpesvirus infection 💬
3件: JAK1, JAK2, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
97 Leishmaniasis 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
98 Leishmaniasis 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
99 Leishmaniasis 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
100 Leishmaniasis 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
101 Leishmaniasis 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
102 Leishmaniasis 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
103 Leishmaniasis 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
104 Leishmaniasis 💬
2件: JAK1, JAK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
105 Measles 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
106 Measles 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
107 Measles 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
108 Measles 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
109 Measles 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
110 Measles 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
111 Measles 💬
2件: JAK1, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
112 Measles 💬
3件: JAK1, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
113 Necroptosis 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
114 Necroptosis 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
115 Necroptosis 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
116 Necroptosis 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
117 Necroptosis 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
118 Necroptosis 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
119 Necroptosis 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
120 Necroptosis 💬
4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
121 NOD-like receptor signaling pathway 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
122 NOD-like receptor signaling pathway 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
123 NOD-like receptor signaling pathway 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
124 NOD-like receptor signaling pathway 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
125 NOD-like receptor signaling pathway 💬
1件: JAK1 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
126 NOD-like receptor signaling pathway 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
127 NOD-like receptor signaling pathway 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
128 NOD-like receptor signaling pathway 💬
2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
129 Osteoclast differentiation 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
130 Osteoclast differentiation 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
131 Osteoclast differentiation 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
132 Osteoclast differentiation 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
133 Osteoclast differentiation 💬
1件: JAK1 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
134 Osteoclast differentiation 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
135 Osteoclast differentiation 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
136 Osteoclast differentiation 💬
2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
137 Pancreatic cancer 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
138 Pancreatic cancer 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
139 Pancreatic cancer 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
140 Pancreatic cancer 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
141 Pancreatic cancer 💬
1件: JAK1 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
142 Pancreatic cancer 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
143 Pancreatic cancer 💬
1件: JAK1 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
144 Pancreatic cancer 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
145 Pathways in cancer 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
146 Pathways in cancer 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
147 Pathways in cancer 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
148 Pathways in cancer 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
149 Pathways in cancer 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
150 Pathways in cancer 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
151 Pathways in cancer 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
152 Pathways in cancer 💬
3件: JAK1, JAK2, JAK3 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
153 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
154 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
155 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
156 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
157 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
158 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
159 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
160 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: JAK1, JAK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
161 PI3K-Akt signaling pathway 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
162 PI3K-Akt signaling pathway 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
163 PI3K-Akt signaling pathway 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
164 PI3K-Akt signaling pathway 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
165 PI3K-Akt signaling pathway 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
166 PI3K-Akt signaling pathway 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
167 PI3K-Akt signaling pathway 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
168 PI3K-Akt signaling pathway 💬
3件: JAK1, JAK2, JAK3 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
169 Signaling pathways regulating pluripotency of stem cells 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
170 Signaling pathways regulating pluripotency of stem cells 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
171 Signaling pathways regulating pluripotency of stem cells 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
172 Signaling pathways regulating pluripotency of stem cells 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
173 Signaling pathways regulating pluripotency of stem cells 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
174 Signaling pathways regulating pluripotency of stem cells 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
175 Signaling pathways regulating pluripotency of stem cells 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
176 Signaling pathways regulating pluripotency of stem cells 💬
3件: JAK1, JAK2, JAK3 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
177 Th1 and Th2 cell differentiation 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
178 Th1 and Th2 cell differentiation 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
179 Th1 and Th2 cell differentiation 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
180 Th1 and Th2 cell differentiation 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
181 Th1 and Th2 cell differentiation 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
182 Th1 and Th2 cell differentiation 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
183 Th1 and Th2 cell differentiation 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
184 Th1 and Th2 cell differentiation 💬
4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
185 Th17 cell differentiation 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
186 Th17 cell differentiation 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
187 Th17 cell differentiation 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
188 Th17 cell differentiation 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
189 Th17 cell differentiation 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
190 Th17 cell differentiation 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
191 Th17 cell differentiation 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
192 Th17 cell differentiation 💬
4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
193 Toxoplasmosis 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
194 Toxoplasmosis 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
195 Toxoplasmosis 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
196 Toxoplasmosis 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
197 Toxoplasmosis 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
198 Toxoplasmosis 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
199 Toxoplasmosis 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
200 Toxoplasmosis 💬
3件: JAK1, JAK2, TYK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
201 Tuberculosis 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
202 Tuberculosis 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
203 Tuberculosis 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
204 Tuberculosis 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
205 Tuberculosis 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
206 Tuberculosis 💬
2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
207 Tuberculosis 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
208 Tuberculosis 💬
2件: JAK1, JAK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
209 Viral carcinogenesis 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬
210 Viral carcinogenesis 💬
1件: JAK1 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
211 Viral carcinogenesis 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬
212 Viral carcinogenesis 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬
213 Viral carcinogenesis 💬
1件: JAK1 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬
214 Viral carcinogenesis 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
215 Viral carcinogenesis 💬
2件: JAK1, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
216 Viral carcinogenesis 💬
2件: JAK1, JAK3 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬